Exfoliation Syndrome: Clinical Trials

72 trials for Exfoliation Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

32 completed, 13 unknown, 12 recruiting, 6 terminated. 25 Not applicable, 4 Phase 4, 3 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable25Completed 8, Recruiting 7, Terminated 3, Unknown 3, Active not recruiting 2, Enrolling by invitation 1, Not yet recruiting 1
Phase 44Completed 3, Recruiting 1
Phase 23Completed 2, Enrolling by invitation 1
Phase 33Completed 3
Phase 11Enrolling by invitation 1

Follow Exfoliation Syndrome: new trials by email Literature Review of Exfoliation Syndrome trials Research Report on Exfoliation Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Insulin for Glaucoma (TING2)
EYED-002 Low Dose (721 U/mL topical insulin), EYED-002 High Dose (1442 U/mL topical insulin), EYED-002 (highest tolerated dose, 12-month) - Open Angle Glaucoma, Primary Open Angle Glaucoma
Phase 1 / Phase 2Enrolling by invitationStanford University902026-09-102026-10-13
Influence of Cataract Surgery on Corneal Biomechanical Properties in Patients With Pseudoexfoliation Syndrome
Pseudoexfoliation Syndrome, Cataract
Not yet recruitingKata Culina702026-07-202026-07-23
Corneal Biomechanics and Surgically Induced Astigmatism in Pseudoexfoliation Syndrome
phacoemulsification cataract surgery - Pseudoexfoliation Syndrome, Cataract
RecruitingKata Culina702026-07-202026-08-18
The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma
Direct selective laser trabeculoplasty - Pseudoexfoliation Glaucoma
Not applicableNot yet recruitingVance Thompson Vision402026-03-012026-02-10
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
iStent infinite trabecular micro-bypass system model iS3, iDose TR (Travoprost intracameral Implant) 75mcg - Open Angle Glaucoma, Pigmentary Glaucoma
Phase 4RecruitingJonathon Myers202026-01-052025-11-14
Pseudoexfoliation and Carpal Tunnel Study
Pseudoexfoliation Syndrome, Carpal Tunnel Syndrome (CTS)
CompletedAnkara Training and Research Hospital1592025-05-012026-04-17
Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma
Transcorneal electrical stimulation (TES) with the OkuStim 2 System - Glaucoma, Primary Open Angle Glaucoma
Not applicableRecruitingOkuvision GmbH502025-04-022026-03-12
Vitamin Mix (B6, B9, B12, And Choline) For Glaucoma Patients
Vitamin B-mix, Standard Care - Open-angle Glaucoma, Pseudoexfoliation Glaucoma
Not applicableRecruitingKarolinska Institutet802025-03-312025-04-29
Corneal Biomechanics, Optical Properties and Anterior Segment Structural Features in Patients With Pseudoexfoliation
Pentacam-AXL, HD Analyzer, Corvis ST - Pseudoexfoliation Syndrome, Biomechanical Parameters
RecruitingAristotle University Of Thessaloniki862024-12-132024-12-27
The Correlation Between Pupil Size and Retinal Nerve Fibers Changes in Pseudoexfoliation Syndrome.
optical coherence tomography - Pseudoexfoliation Syndrome
Not yet recruitingAssiut University332024-12-012024-09-19
Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt
Suprachoroidal silicone tube (SST) shunt - Glaucoma, Open Angle Glaucoma (OAG)
RecruitingDavinci LTD662024-11-082024-11-15
XEN Glaucoma Gel Stent Versus Trabeculectomy
surgery - Primary Open Angle Glaucoma, Pseudoexfoliation Glaucoma
Not applicableRecruitingProf. Dr. Herbert Reitsamer1962023-12-202025-06-03
Safety and Efficacy of Suprachoroidal Tube Shunt in Patients With Primary Open and Pseudoexfoliation Glaucomas
Glaucoma, Open-Angle, Suprachoroidal Space
UnknownDavinci LTD912023-11-202023-12-04
Uddevalla Skövde Transscleral Micropulse Study
Topical lidocaine, MP-TLT - Primary Open Angle Glaucoma, Pseudoexfoliation Glaucoma
Enrolling by invitationVastra Gotaland Region402023-10-062024-12-03
Outcome of Two Surgical Methods for IOLImplantation in Eyes With Pseudoexfoliation Syndrome
Phakoemulsification, Ziemer Z8 Femtolaser, Kowa Avansee Preset - Age Related Cataracts, Pseudoexfoliation Syndrome
Not applicableRecruitingMedical University of Vienna1202023-09-182023-10-24
Vitreous Proteomics of Patients Suffering From Pseudoexfoliation Syndrome
Liquid chromatography mass spectrometry - Pseudoexfoliation Syndrome
Not applicableActive not recruitingPrim. Prof. Dr. Oliver Findl, MBA242023-07-062026-04-07
Trabeculopuncture as Predictive Test for the Success of Ab Interno Trabeculectomy
Trabeculopuncture - Open Angle Glaucoma, Pseudoexfoliation Glaucoma
Not applicableRecruitingWuerzburg University Hospital552023-06-132025-04-03
Pseudoexfoliation Syndrome, Sarcopenia and Chronic Pain
SARC-F questionnaire, Gait speed, The chair rise test - Sarcopenia, Pseudoexfoliation Syndrome
CompletedEskisehir Osmangazi University962023-03-302023-11-08
Phacoemulsification vs SLT as Initial Treatment for Pseudoexfoliation Glaucoma
Phacoemulsification, Selective Laser Trabeculoplasty - Pseudoexfoliation Glaucoma
Not applicableRecruitingNova Scotia Health Authority2002022-10-102024-08-21
The Possible Association Between Pseudoexfoliation Syndrome And Corneal Endothelial Cell Changes
no interventions as it is a case control observational study - Pseudoexfoliation Syndrome
UnknownAssiut University502022-01-242021-12-14

Showing 20 of 72. Sign in to see all of them.

Narrower conditions

Glaucoma, Open-Angle (36)  ·  Glaucoma (20)  ·  Cataract (14)  ·  Ocular Hypertension (13)  ·  Glaucoma, Angle-Closure (4)  ·  Glaucoma, Neovascular (3)  ·  Choroidal Effusions (2)  ·  Diabetes Mellitus (2)  ·  Hypertension (2)  ·  Low Tension Glaucoma (2)  ·  Mydriasis (2)  ·  Aortic Aneurysm, Abdominal (1)  ·  Astigmatism (1)  ·  Carpal Tunnel Syndrome (1)

Broader conditions

Eye Diseases (72)  ·  Iris Diseases (72)  ·  Uveal Diseases (72)  ·  Ocular Hypertension (29)  ·  Glaucoma (22)  ·  Lens Diseases (14)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Eye Abnormalities (4)  ·  Signs and Symptoms (4)  ·  Nervous System Diseases (3)  ·  Pupil Disorders (3)  ·  Cardiovascular Diseases (2)  ·  Choroid Diseases (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)

Interventions

Phacoemulsification (5)  ·  Cataract Extraction (2)  ·  Lubricant Eye Drops (2)  ·  Timolol (2)  ·  Travoprost (2)  ·  1(beta)-D-arabinofuranosylcytosine-5'-diphosphate prednisolone (1)  ·  AR-12286 (1)  ·  Blood Specimen Collection (1)  ·  Brimonidine Tartrate (1)  ·  Hand Strength (1)  ·  Hanks Balanced Salt Solution (1)  ·  Insulin (1)  ·  Ketorolac Tromethamine (1)  ·  Latanoprost (1)  ·  Lidocaine (1)

Sponsors

Aristotle University Of Thessaloniki (5)  ·  Assiut University (4)  ·  St. Erik Eye Hospital (4)  ·  Medical University of Vienna (3)  ·  Vastra Gotaland Region (3)  ·  Davinci LTD (2)  ·  General Hospital Sveti Duh (2)  ·  Kata Culina (2)  ·  Nova Scotia Health Authority (2)  ·  Wills Eye (2)  ·  Xerencia de Xestión Integrada de Ferrol (2)  ·  Alcon Research (1)  ·  Anglia Ruskin University (1)  ·  Ankara Training and Research Hospital (1)  ·  AqueSys, Inc. (1)

Countries

United States (13)  ·  Sweden (9)  ·  Austria (7)  ·  Greece (5)  ·  Canada (4)  ·  Croatia (3)  ·  Egypt (3)  ·  Turkey (Türkiye) (3)  ·  Finland (2)  ·  Georgia (2)  ·  Germany (2)  ·  Italy (2)  ·  Spain (2)  ·  Switzerland (2)  ·  Colombia (1)

Top investigators

Marcelo Ayala, MD, PhD (3)  ·  Tobias Dahlgren, MD (3)  ·  Enping Chen, MD Ph D (2)  ·  Anastasios G Konstas, MD, PhD (1)  ·  Andrew C Crichton (1)  ·  Antonios T Dimopoulos, MD (1)  ·  Changwon Kee, M.D., PhD (1)  ·  Constantine D Georgakopoulos, MD, PhD (1)  ·  Daniel Kampik, MD, PhD (1)  ·  Delan Jinapriya, MD (1)  ·  Dilru Amarasekera, MD (1)  ·  Douglas G. Day, MD (1)  ·  Elizabeth D. Sharpe, MD (1)

Results publications

PMID 18552979, PMID 18648524, PMID 19485285, PMID 24794283, PMID 29267575, PMID 30488265, PMID 32890108, PMID 35943114, PMID 36564963, PMID 40764517, PMID 41084053, PMID 41663170

NIH funding

2023 (1), UL1TR001082 (1)